List of vaccine topics

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe or its toxins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.[1]

Flu vaccine

This is a list of vaccine-related topics.

Human vaccines

Viral diseases
VirusDiseases or conditionsVaccine(s)Brands
Dengue virusDengue feverDengue vaccineDengvaxia
Hepatitis A virusHepatitis AHepatitis A vaccineHavrix, Avaxim, VAQTA, Epaxal, Twinrix, Biovac-A
Hepatitis B virusHepatitis BHepatitis B vaccineSci-B-Vac. Engerix-B, Recombivax HB, Elovac B, Genevac B, Shanvac B, Twinrix, Comvax, Pediarix, Pentabio, Quinvaxem, Pentavac PFS, Easyfive TT, Shan-5, ComBE Five
Hepatitis E virusHepatitis EHepatitis E vaccineHecolin
Human papillomavirusCervical cancer, Genital warts, anogenital cancersHPV vaccineCervarix, Gardasil
Influenza virusInfluenzaInfluenza vaccineFluMist, Fluzone, Influvac, Vaxigrip, Fluarix, Fluvirin, FluLaval, Agriflu, Flubio
Japanese encephalitis virusJapanese encephalitisJapanese encephalitis vaccineIxiaro, Jespect, Imojev, JEvax, Jenvac, Jeev, Encevac
Measles virusMeaslesMeasles vaccine, MMR vaccine, MMRV vaccinePriorix, MMR II, Tresivac, Trimovax, ProQuad, Priorix Tetra
Mumps virusMumpsMumps vaccine, MMR vaccine, MMRV vaccine Priorix, MMR II, Tresivac, Trimovax, ProQuad, Priorix Tetra
Polio virusPoliomyelitisPolio vaccineKinrix, Quadracel, Pediarix, Pentacel, Pediacel, Ipol
Rabies virusRabiesRabies vaccineImovax, RabAvert, Rabipur, Abhayrab, Speeda, Verorab, Rabivax
RotavirusRotaviral gastroenteritisRotavirus vaccineRotateq, Rotarix
Rubella virusRubellaRubella vaccine, MMR vaccine, MMRV vaccinePriorix, MMR II, Tresivac, Trimovax, ProQuad
Tick-borne encephalitis virusTick-borne encephalitisTick-borne encephalitis vaccineFSME-Immun, Encepur, TBE-Moscow, EnceVi
Varicella zoster virusChickenpox, ShinglesVaricella vaccine, Shingles vaccine, MMRV vaccineVarivax, Zostavax, ProQuad, Priorix Tetra
Variola virusSmallpoxSmallpox vaccineDryvax, ACAM2000, Imvanex
Yellow fever virusYellow feverYellow fever vaccineYF-VAX, Stamaril

Bacterial diseases
BacteriumDiseases or conditionsVaccine(s)Brands
Bacillus anthracisAnthraxAnthrax vaccinesBioThrax
Bordetella pertussisWhooping coughDPT vaccineBoostrix, Adacel, Daptacel, Infanrix, Tripedia, Kinrix, Pediarix, Pentacel, Tetramune, Quinvaxem, Pentavac PFS, Easyfive TT, Shan-5, ComBE Five
Clostridium tetaniTetanusDPT vaccineBoostrix, Adacel, Decavac, Tenivac, Daptacel, Infanrix, Tripedia, Kinrix, Pediarix, Pentacel, Tetramune, Quinvaxem, Pentavac PFS, Easyfive TT, Shan-5, ComBE Five
Corynebacterium diphtheriaeDiphtheriaDPT vaccineBoostrix, Adacel, Decavac, Tenivac, Daptacel, Infanrix, Tripedia, Kinrix, Pediarix, Pentacel, Tetramune, Quinvaxem, Pentavac PFS, Easyfive TT, Shan-5, ComBE Five
Coxiella burnetiiQ feverQ fever vaccineQ-Vax
Haemophilus influenzae type B (Hib)Epiglottitis, meningitis, pneumoniaHib vaccineHiberix, Pentacel, ActHIB, Pedvax HIB, Tetramune, Quinvaxem, Pentavac PFS, Easyfive TT, Shan-5, ComBE Five
Mycobacterium tuberculosisTuberculosisTuberculosis (BCG) vaccineTice BCG
Neisseria meningitidisMeningococcal meningitisMeningococcal vaccineSerotype C: Neisvac C and Meningitec. Serotypes A/C/W-135/Y: Mencevax, Nimenrix, Menveo, Menactra. Serotype B: Bexsero
Salmonella typhiTyphoid feverTyphoid vaccineTyphim Vi, Typherix, Ty21a
Streptococcus pneumoniaePneumococcal pneumoniaPneumococcal conjugate vaccine, Pneumococcal polysaccharide vaccinePneumovax, Prevnar
Vibrio choleraeCholeraCholera vaccineDukoral, Shanchol

Vaccines under research

Viral diseases

Bacterial diseases

Parasitic diseases

Non-infectious diseases

Vaccine components

Vaccine trials

Vaccination strategies

Vaccine safety

People

Developers of vaccines

Organizations, conferences and publications
Manufacturers
Other
Advocacy of anti-vaccination opinions

Other
gollark: Maybe I should split it into sentences.
gollark: Not even regexes.
gollark: It uses some of the least advanced NLP in any of my bots.
gollark: Hmm. Maybe I should actually work out how to implement highly generalized forms of bias. But *which*?
gollark: It would also have been quite hard to bias it against *lyricly* health, since it was me running the ++choose.

See also
  • Indian states ranking by vaccination coverage

References
  1. Loehr, Jamie (2009). "Vaccine Basics". The Vaccine Answer Book. Naperville, IL: Sourcebooks Inc. ISBN 978-1402223785.
  2. Kuschner, R. A.; Russell, K. L.; Abuja, M.; Bauer, K. M.; Faix, D. J.; Hait, H.; Henrick, J.; Jacobs, M.; Liss, A.; Lynch, J. A.; Liu, Q.; Lyons, A. G.; Malik, M.; Moon, J. E.; Stubbs, J.; Sun, W.; Tang, D.; Towle, A. C.; Walsh, D. S.; Wilkerson, D.; Adenovirus Vaccine Efficacy Trial Consortium (2013). "A phase 3, randomized, double-blind, placebo-controlled study of the safety and efficacy of the live, oral adenovirus type 4 and type 7 vaccine, in U.S. Military recruits". Vaccine. 31 (28): 2963–2971. doi:10.1016/j.vaccine.2013.04.035. PMID 23623865.
  3. Kim, D. S.; Nam, J. H. (2010). "Characterization of attenuated coxsackievirus B3 strains and prospects of their application as live-attenuated vaccines". Expert Opinion on Biological Therapy. 10 (2): 179–190. doi:10.1517/14712590903379502. PMID 20088713.
  4. Schleiss, M. R. (2008). "Cytomegalovirus vaccine development". Human Cytomegalovirus. Current Topics in Microbiology and Immunology. 325. pp. 361–382. doi:10.1007/978-3-540-77349-8_20. ISBN 978-3-540-77348-1. PMC 2831992. PMID 18637516.
  5. Docksai, Rick (31 May 2017). "https://www.defense.gov/News/Article/Article/1198160/dod-vaccine-research-saves-military-civilian-lives/". US Department of Defense. Retrieved 7 July 2018. External link in |title= (help)
  6. Myles, R. (December 2, 2012). "France's Sanofi Pasteur to release Dengue fever vaccine". Digital Journal. Retrieved April 24, 2013.
  7. Pandya, J.; Gorchakov, R.; Wang, E.; Leal, G.; Weaver, S. C. (2012). "A vaccine candidate for eastern equine encephalitis virus based on IRES-mediated attenuation". Vaccine. 30 (7): 1276–1282. doi:10.1016/j.vaccine.2011.12.121. PMC 3283035. PMID 22222869.
  8. Erickson, D. (January 21, 2013). "Hamilton researchers help make breakthrough on Ebola vaccine". Billings Gazette. Retrieved May 29, 2013.
  9. Zhu, F. C.; Liang, Z. L.; Li, X. L.; Ge, H. M.; Meng, F. Y.; Mao, Q. Y.; Zhang, Y. T.; Hu, Y. M.; Zhang, Z. Y.; Li, J. X.; Gao, F.; Chen, Q. H.; Zhu, Q. Y.; Chu, K.; Wu, X.; Yao, X.; Guo, H. J.; Chen, X. Q.; Liu, P.; Dong, Y. Y.; Li, F. X.; Shen, X. L.; Wang, J. Z. (2013). "Immunogenicity and safety of an enterovirus 71 vaccine in healthy Chinese children and infants: A randomised, double-blind, placebo-controlled phase 2 clinical trial". The Lancet. 381 (9871): 1037–45. doi:10.1016/S0140-6736(12)61764-4. PMID 23352749.
  10. Pullen, L.C. (November 7, 2011). "Epstein-Barr Virus Vaccine May Soon Enter Phase 3 Trial". Medscape Today. Retrieved April 24, 2013.
  11. "Hepatitis C vaccine by Inovio could be tested in humans by end of year". Philadelphia Business Journal. January 9, 2013. Retrieved April 24, 2013.
  12. "Researchers a step closer to making HIV vaccine". Medical News Today. April 5, 2013. Retrieved April 24, 2013.
  13. Hanabuchi, S.; Ohashi, T.; Koya, Y.; Kato, H.; Hasegawa, A.; Takemura, F.; Masuda, T.; Kannagi, M. (2001). "Regression of human T-cell leukemia virus type I (HTLV-I)-associated lymphomas in a rat model: Peptide-induced T-cell immunity". Journal of the National Cancer Institute. 93 (23): 1775–1783. doi:10.1093/jnci/93.23.1775. PMID 11734593.
  14. De Thé, G.; Bomford, R.; Kazanji, M.; Ibrahim, F. (1994). "Human T cell lymphotropic virus: Necessity for and feasibility of a vaccine". Ciba Foundation Symposium. Novartis Foundation Symposia. 187: 47–55, discussion 55–60. doi:10.1002/9780470514672.ch4. ISBN 9780470514672. PMID 7796676.
  15. Hampton, T. (2006). "Marburg Vaccine Shows Promise: Offers Postexposure Protection in Monkeys". JAMA. 295 (20): 2346. doi:10.1001/jama.295.20.2346. PMID 16720816.
  16. Sifferlin, A. (March 22, 2013). "Norovirus leading cause of intestinal disorders in kids". CNN. Retrieved April 24, 2013.
  17. Lindell, D. M.; Morris, S. B.; White, M. P.; Kallal, L. E.; Lundy, P. K.; Hamouda, T.; Baker, J. R.; Lukacs, N. W. (2011). Semple, Malcolm Gracie (ed.). "A Novel Inactivated Intranasal Respiratory Syncytial Virus Vaccine Promotes Viral Clearance without Th2 Associated Vaccine-Enhanced Disease". PLOS ONE. 6 (7): e21823. Bibcode:2011PLoSO...621823L. doi:10.1371/journal.pone.0021823. PMC 3137595. PMID 21789184.
  18. Jiang, S.; Lu, L.; Du, L. (2013). "Development of SARS vaccines and therapeutics is still needed". Future Virology. 8 (1): 1–2. doi:10.2217/fvl.12.126. PMC 7079997. PMID 32201503.
  19. Hall, R. A.; Khromykh, A. A. (2004). "West Nile virus vaccines". Expert Opinion on Biological Therapy. 4 (8): 1295–1305. doi:10.1517/14712598.4.8.1295. PMID 15268663.
  20. Sifferlin, Alexandra (21 January 2016). "U.S. Launches 'Full-court Press' for a Zika Vaccine". Time. Retrieved 23 January 2016.
  21. Shivakumar, K. M.; Vidya, S. K.; Chandu, G. N. (2009). "Dental caries vaccine". Indian Journal of Dental Research. 20 (1): 99–106. doi:10.4103/0970-9290.49066. PMID 19336869.
  22. Rudoler, N.; Baneth, G.; Eyal, O.; Van Straten, M.; Harrus, S. (2012). "Evaluation of an attenuated strain of Ehrlichia canis as a vaccine for canine monocytic ehrlichiosis". Vaccine. 31 (1): 226–233. doi:10.1016/j.vaccine.2012.10.003. PMID 23072894.
  23. McGuinness, R. (November 20, 2012). "Search for leprosy vaccine continues as disease still affects thousands". Metro News. Retrieved May 29, 2013.
  24. "Lyme Disease Vaccine". Lyme Info. Retrieved April 24, 2013.
  25. Bagnoli, F.; Bertholet, S.; Grandi, G. (2012). "Inferring Reasons for the Failure of Staphylococcus aureus Vaccines in Clinical Trials". Frontiers in Cellular and Infection Microbiology. 2: 16. doi:10.3389/fcimb.2012.00016. PMC 3417391. PMID 22919608.
  26. Guilherme, L.; Ferreira, F. M.; Köhler, K. F.; Postol, E.; Kalil, J. (2013). "A Vaccine against Streptococcus pyogenes". American Journal of Cardiovascular Drugs. 13 (1): 1–4. doi:10.1007/s40256-013-0005-8. PMID 23355360.
  27. Cullen, P. A.; Cameron, C. E. (2006). "Progress towards an effective syphilis vaccine: The past, present and future". Expert Review of Vaccines. 5 (1): 67–80. doi:10.1586/14760584.5.1.67. PMID 16451109.
  28. Conlan, J. W. (2011). "Tularemia vaccines: Recent developments and remaining hurdles". Future Microbiology. 6 (4): 391–405. doi:10.2217/fmb.11.22. PMID 21526941.
  29. Titball, R. W.; Williamson, E. D. (2004). "Yersinia pestis (plague) vaccines". Expert Opinion on Biological Therapy. 4 (6): 965–973. doi:10.1517/14712598.4.6.965. PMID 15174978.
  30. Vogel, G. (March 20, 2013). "More Sobering Results for Malaria Vaccine". Science Magazine. Archived from the original on May 10, 2013. Retrieved April 24, 2013.
  31. Siddiqui, A. A.; Siddiqui, B. A.; Ganley-Leal, L. (2011). "Schistosomiasis vaccines". Human Vaccines. 7 (11): 1192–1197. doi:10.4161/hv.7.11.17017. PMC 3323497. PMID 22048120.
  32. "Potential Chagas Vaccine Candidate Shows Unprecedented Efficacy". Science Daily. 26 March 2013. Retrieved 14 September 2013.
  33. "Human hookworm vaccine trial". Medical News Today. January 20, 2012. Retrieved April 24, 2013.
  34. Sanjit Bagchi (April 26, 2006). "Study raises hopes of vaccine for river blindness". SciDev Net. Retrieved April 24, 2013.
  35. La Greca, F.; Magez, S. (2011). "Vaccination against trypanosomiasis: Can it be done or is the trypanosome truly the ultimate immune destroyer and escape artist?". Human Vaccines. 7 (11): 1225–1233. doi:10.4161/hv.7.11.18203. PMC 3323498. PMID 22205439.
  36. Nakkazi, E. (March 12, 2012). "New vaccine trials to prevent visceral leishmaniasis". New Science Journalism. Retrieved June 16, 2013.
  37. Keller, D. M. (April 22, 2013). "Alzheimer's Vaccine Shows Efficacy Without Adverse Effects". Medscape News. Retrieved May 29, 2013.
  38. McFadden, M. (October 11, 2012). "Revolutionary breast cancer vaccine 100% effective in mice: awaits human trials". WNDU. Retrieved May 12, 2013.
  39. "Ovarian cancer vaccine shows promise in trial". Fox News. April 8, 2013. Retrieved April 24, 2013.
  40. Jonhson, K. (March 21, 2013). "Prostate Cancer Vaccine Shows Promise". Medscape Today. Retrieved April 24, 2013.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.